Showing results (131-140 of 288) with videos related to
Sort By:
Pageof 29
Brain, Behavior, and Immunity|April 10, 2025
Fueling the fire in the lung-brain axis: The salience network connects allergen-provoked TH17 responses to psychological stress in asthmaEstelle T Higgins, William W Busse, Stephane Esnault, et al.Journal of Negative Results in Biomedicine|June 15, 2014
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroidsJan Lötvall, Eric D Bateman, William W Busse, et al.American Journal of Respiratory Cell and Molecular Biology|April 24, 2002
Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cellsShinichi Konno, Kristine A Grindle, Wai-Ming Lee, et al.Respiratory Research|November 14, 2013
Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responsesYury A Bochkov, William W Busse, Rebecca A Brockman-Schneider, et al.The Lancet. Respiratory Medicine|November 13, 2018
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trialWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.The Journal of Allergy and Clinical Immunology|February 20, 2021
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatmentWilliam W Busse, Eugene R Bleecker, J Mark FitzGerald, et al.Allergy and Asthma Proceedings|February 20, 2010
Comparative effect of body mass index on response to asthma controller therapyE Rand Sutherland, Carlos A Camargo, William W Busse, et al.American Journal of Respiratory and Critical Care Medicine|February 10, 2009
Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma controlLoren C Denlinger, Lei Shi, Arturo Guadarrama, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 27, 2010
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukastCarlos A Camargo, Louis-Philippe Boulet, E Rand Sutherland, et al.BMC Pulmonary Medicine|May 1, 2016
Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trialJames F Donohue, Robert Wise, William W Busse, et al.Pageof 29